Last reviewed · How we verify

NCT04709146

The Influence of Covid-19 on the Audio-vestibular System

Status unknown NA Last updated 14 January 2021
What this trial tests

NA trial testing Audio-Vestibular evaluation in Covid19 in 70 participants. Status unknown.

Timeline
1 March 2021
Primary endpoint
28 February 2022
30 June 2022

Quick facts

Lead sponsorHaEmek Medical Center, Israel
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment70
Start date1 March 2021
Primary completion28 February 2022
Estimated completion30 June 2022

Drugs / interventions tested

Conditions studied

Sponsor

HaEmek Medical Center, Israel

Who can join

Adults 18 to 80, any sex, with Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the study's porpuse is to examine whether Covid-19 causese a reduction in sensorineural hearing and vestibular function in recovered pateints - compared to healthy controls. Both study groups will undergo audiometry, tympanometry, Video Head Impulse testing, Subjective Visual Vertigo testing and Video-Nystamography. Previous audiometry results will also be aquired.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

Other HaEmek Medical Center, Israel trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04709146.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing